TY - JOUR
T1 - Human CD127 negative ILC2s show immunological memory
AU - Mathä, Laura
AU - Krabbendam, Lisette
AU - Høyer, Sergio Martinez
AU - Heesters, Balthasar A.
AU - Golebski, Korneliusz
AU - Kradolfer, Chantal
AU - Ghaedi, Maryam
AU - Ma, Junjie
AU - Stadhouders, Ralph
AU - Bachert, Claus
AU - Cardell, Lars Olaf
AU - Zhang, Nan
AU - Holtappels, Gabriele
AU - Reitsma, Sietze
AU - Helgers, Leanne Carijn
AU - Geijtenbeek, Teunis B.H.
AU - Coquet, Jonathan M.
AU - Takei, Fumio
AU - Spits, Hergen
AU - Martinez-Gonzalez, Itziar
N1 - Publisher Copyright:
© 2024 Mathä et al.
PY - 2024/6/18
Y1 - 2024/6/18
N2 - ILC2s are key players in type 2 immunity and contribute to maintaining homeostasis. ILC2s are also implicated in the development of type 2 inflammation–mediated chronic disorders like asthma. While memory ILC2s have been identified in mouse, it is unknown whether human ILC2s can acquire immunological memory. Here, we demonstrate the persistence of CD45RO, a marker previously linked to inflammatory ILC2s, in resting ILC2s that have undergone prior activation. A high proportion of these cells concurrently reduce the expression of the canonical ILC marker CD127 in a tissue-specific manner. Upon isolation and in vitro stimulation of CD127−CD45RO+ ILC2s, we observed an augmented ability to proliferate and produce cytokines. CD127−CD45RO+ ILC2s are found in both healthy and inflamed tissues and display a gene signature of cell activation. Similarly, mouse memory ILC2s show reduced expression of CD127. Our findings suggest that human ILC2s can acquire innate immune memory and warrant a revision of the current strategies to identify human ILC2s.
AB - ILC2s are key players in type 2 immunity and contribute to maintaining homeostasis. ILC2s are also implicated in the development of type 2 inflammation–mediated chronic disorders like asthma. While memory ILC2s have been identified in mouse, it is unknown whether human ILC2s can acquire immunological memory. Here, we demonstrate the persistence of CD45RO, a marker previously linked to inflammatory ILC2s, in resting ILC2s that have undergone prior activation. A high proportion of these cells concurrently reduce the expression of the canonical ILC marker CD127 in a tissue-specific manner. Upon isolation and in vitro stimulation of CD127−CD45RO+ ILC2s, we observed an augmented ability to proliferate and produce cytokines. CD127−CD45RO+ ILC2s are found in both healthy and inflamed tissues and display a gene signature of cell activation. Similarly, mouse memory ILC2s show reduced expression of CD127. Our findings suggest that human ILC2s can acquire innate immune memory and warrant a revision of the current strategies to identify human ILC2s.
UR - http://www.scopus.com/inward/record.url?scp=85202740528&partnerID=8YFLogxK
U2 - 10.1084/jem.20231827
DO - 10.1084/jem.20231827
M3 - Article
C2 - 38889332
AN - SCOPUS:85202740528
SN - 0022-1007
VL - 221
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 8
M1 - e20231827
ER -